DUBLIN, May 25, 2016 /PRNewswire/ --
Research and Markets has announced the addition of the "Global RespiratoryDrugs Market 2016-2020" report to their offering.
(Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO )
The global respiratory drugs market to grow at a CAGR of 6.48% during the period 2016-2020.
- AstraZeneca - Boehringer Ingelheim - F.Hoffman La-Roche - GlaxoSmithKline - Merck - Novartis Key Topics Covered: Part 01: Executive summary Part 02: Scope of the report Part 03: Market research methodology Part 04: Introduction Part 05: Overview: Respiratory diseases Part 06: Pipeline analysis Part 07: Market landscape Part 08: Market segmentation by class of drugs Part 09: Market segmentation by disease Part 10: Geographical segmentation Part 11: Market drivers Part 12: Impact of drivers Part 13: Market challenges Part 14: Impact of drivers and challenges Part 15: Market trends Part 16: Vendor landscape Part 17: Appendix For more information visit http://www.researchandmarkets.com/research/86g5tj/global
Media Contact: Laura Wood, Senior Manager email@example.com
For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
Subscribe to our Free Newsletters!
Fallopian tube cancer is a form of gynecologic cancer arising in the fallopian tubes, which are ...
Cushing syndrome is a collection of symptoms caused due to excessive amount of cortisol in the body ...
CAR T-cell therapy is a type of gene therapy where the patient's T-lymphocytes are genetically ...View All